← Leaderboards
Lacey R McNally
University Of Oklahoma Hlth Sciences Ctr
$8,482,397
Attributed
$10,878,838
Total exposure
10
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2009–25$2.5M$1.9M$1.3M$625K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,878,838 · 10
By mechanism
R01$9,470,981 · 5
R00$710,099 · 1
R21$362,664 · 1
K99$180,000 · 1
P30$155,094 · 2
Top collaborators
- Maged M Henary3 shared
- Ajay Jain3 shared
- Jennifer Lin Holter Chakrabarty2 shared
Most similar at University Of Oklahoma Hlth Sciences Ctr
Same institution · by research overlap
- Ajay Jain$1,449,469
- Jennifer Lin Holter Chakrabarty$1,638,189
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoMalignant NeoplasmsContrast MediaTumorImageOptoacoustic TomographyResponseDyesDetectionIn VitroBiodistributionTissuesClinical TrialsMolecularNeoplasm MetastasisMalignant Neoplasm Of PancreasChemotherapyPharmaceutical PreparationsSignal TransductionDoseExcisionImaging ModalityExtracellularNeoplastic Cell
Grant awards (32)
Development of contrast agents to facilitate image-guided surgery$1,728,268
R01 · FY2025 · CA · contact PI
Development of an apoptosis biosensor for monitoring of breast cancer$533,998
R01 · FY2025 · EB · contact PI
Cancer Therapeutics Program$50,338
P30 · FY2025 · CA · contact PI
Development of contrast agents to facilitate image-guided surgery$563,640
R01 · FY2024 · CA · contact PI
Development of an apoptosis biosensor for monitoring of breast cancer$502,136
R01 · FY2024 · EB · contact PI
Non-invasive assessment of graft vs host disease using optoacoustic imaging$193,195
R21 · FY2024 · CA
Cancer Therapeutics Program$52,379
P30 · FY2024 · CA · contact PI
Development of contrast agents to facilitate image-guided surgery$607,029
R01 · FY2023 · CA · contact PI
Development of an apoptosis biosensor for monitoring of breast cancer$495,147
R01 · FY2023 · EB · contact PI
Non-invasive assessment of graft vs host disease using optoacoustic imaging$169,469
R21 · FY2023 · CA
Cancer Therapeutics Program$52,377
P30 · FY2023 · CA · contact PI
Stroma Targeted Theranostic Nanoparticles for Pancreatic Cancer$327,188
R01 · FY2021 · CA · contact PI
Non-Invasive Detection of Tumor Extracellular pH using Multispectral Optoacoustic Tomography$321,146
R01 · FY2021 · CA · contact PI
Stroma Targeted Theranostic Nanoparticles for Pancreatic Cancer$327,188
R01 · FY2020 · CA · contact PI
Non-Invasive Detection of Tumor Extracellular pH using Multispectral Optoacoustic Tomography$323,588
R01 · FY2020 · CA · contact PI
Theranostic Nanoparticles For Detection and Treatment of Pancreatic Cancer$353,654
R01 · FY2019 · EB · contact PI
Non-invasive detection of tumor extracellular pH using multispectral optoacoustic tomography$342,238
R01 · FY2019 · CA · contact PI
Stroma targeted theranostic nanoparticles for pancreatic cancer$330,847
R01 · FY2019 · CA · contact PI
Theranostic nanoparticles for detection and treatment of pancreatic cancer$378,267
R01 · FY2018 · EB · contact PI
Non-invasive detection of tumor extracellular pH using multispectral optoacoustic tomography$354,563
R01 · FY2018 · CA · contact PI
Stroma targeted theranostic nanoparticles for pancreatic cancer$354,563
R01 · FY2018 · CA · contact PI
Deep Learning in the context of Multispectral optoacoustic tomography Administrative supplement$133,300
R01 · FY2018 · EB · contact PI
Theranostic nanoparticles for detection and treatment of pancreatic cancer$394,421
R01 · FY2017 · EB · contact PI
Stroma targeted theranostic nanoparticles for pancreatic cancer$354,563
R01 · FY2017 · CA · contact PI
Theranostic nanoparticles for detection and treatment of pancreatic cancer$392,891
R01 · FY2016 · EB · contact PI
Non-invasive detection of tumor extracellular pH using multispectral optoacoustic tomography$318,294
R01 · FY2016 · CA · contact PI
Non-invasive detection of tumor extracellular pH using multispectral optoacoustic tomography$34,052
R01 · FY2016 · CA · contact PI
KiSS1 treatment of pancreatic adenocarcinoma$227,040
R00 · FY2013 · CA · contact PI
KiSS1 treatment of pancreatic adenocarcinoma$241,530
R00 · FY2012 · CA · contact PI
KiSS1 treatment of pancreatic adenocarcinoma$241,529
R00 · FY2011 · CA · contact PI
KiSS1 treatment of pancreatic adenocarcinoma$90,000
K99 · FY2010 · CA · contact PI
KiSS1 treatment of pancreatic adenocarcinoma$90,000
K99 · FY2009 · CA · contact PI